📰 ET Markets 🟢 BULLISH 🕒 29 Oct 2026, 12:44 PM IST

HUL shares rise 3% after Q2 results. Jefferies, Nomura cut target price but forecast 29% upside potential

⚡ Instant Key Takeaways (TL;DR)

🎯

Core Development: HUL shares rise 3% after Q2 results. Jefferies, Nomura cut target price but forecast 29% upside potential

📊

Market & Financial Impact: Hindustan Unilever shares rose on Thursday after the FMCG major reported a 4% year-on-year increase in Q2 FY27 net profit to Rs 2,790 crore and 15% revenue growth to Rs 18,226 crore. Jefferies, Nomura and JM Financial cut their target prices but continue to see upside potential of up to 29%.

💡

Actionable Insight: 🟢 Bullish Trigger: Positive business expansion or earnings beat may attract institutional and retail buying.

Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

KYC and KYB: Inside Damani’s DMart, the retail chain for the middle class. And stock for the long term? – Part 2 of 3

Will it be a regulatory nightmare if an exchange lists on its own platform?

KYC and KYB: Inside Damani’s Avenue Supermarts that refuses to charge more – Part 1 of 3

📰

Official Publisher Attribution: This report is aggregated from Economic Times. ZeroLive provides live aggregation, automated sentiment synthesis, and exchange disclosure monitoring for retail market participants.

Read Original Full Coverage on Economic Times ↗

⚡

Get Breaking Stock Alerts & Q-Results on Telegram

Real-time 1200x675 image cards and financial filings delivered instantly.

Join @Zerolive_news ↗

HUL shares rise 3% after Q2 results. Jefferies, Nomura cut target price but forecast 29% upside potential

🔥 More Live Market Stories

Anthropic worth $1.48 trillion, below potential IPO valuation, says Aswath Damodaran

[APARINDS] Appointment - Apar Industries Limited

[RPEL] Updates - Raghav Productivity Enhancers Limited

[SENORES] Capacity addition - Senores Pharmaceuticals Limited

15% return in week! Small cap under ₹50 hits 4th upper circuit - What's next for investors? Q2, stop loss, target

Fluidra narrows 2026 guidance after third quarter results